Delivery Order SPE2DB20D1004-SPE2DB23FE8G2

Award Date 11/4/22
Potential Completion Date 11/7/22
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $1,347.39, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00. The IDC serves as a primary vehicle for...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,078.57 firm fixed-price delivery order was issued on August 1, 2022, with an ultimate completion date of August 2, 2022. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,180.52 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2023, with a completion date of January 18, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key supplier of...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $3,657.93 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 26, 2022. The contract has an ultimate completion date of September 27, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 15, 2022 with a ceiling value of $1,941.12. This is a delivery order contract with a firm fixed price. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injector devices to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,785.06 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has a firm fixed-price pricing type and an ultimate completion date of December 4, 2024. This delivery order is a component of a...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, valued at $1,856.40. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of 4,557,370,375 Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC is a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $3,020.72, is a delivery order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,560,094 units of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,945.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FE8G2
    Delivery Order

This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,174.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2022 with a completion date of November 7, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and other critical care items, to support military treatment facilities and Department of Veterans Affairs healthcare programs. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:17 PM